TrialEuropean urology2015

Long-term Efficacy and Safety of Enzalutamide Monotherapy in Hormone-naïve Prostate Cancer: 1- and 2-Year Open-label Follow-up Results.

Bertrand Tombal et al.PubMed ↗Publisher ↗

No numbers read from the abstract.